Market Research Logo

Europe Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

Europe Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Non-Small Cell Lung Cancer patients study in a new report ‘Europe Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer diagnosed patients, and Non-Small Cell Lung Cancer treatment rate for EU5 pharmaceutical markets. The study measures key indicators such as prevalence of Non-Small Cell Lung Cancer derived from epidemiological analysis, percentage of patients diagnosed with Non-Small Cell Lung Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Non-Small Cell Lung Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Non-Small Cell Lung Cancer prevalence, Non-Small Cell Lung Cancer diagnosis rate, and Non-Small Cell Lung Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including Germany, France, Spain, Italy, and UK. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Non-Small Cell Lung Cancer Patient Flow
  • Non-Small Cell Lung Cancer Prevalence
  • Non-Small Cell Lung Cancer Diagnosed Patients
  • Non-Small Cell Lung Cancer Treated Patients


1. Non-Small Cell Lung Cancer: Disease Definition
2. Non-Small Cell Lung Cancer Patient Flow in Europe
2A. Non-Small Cell Lung Cancer Prevalence in Europe
2B. Non-Small Cell Lung Cancer Diagnosed Patients in Europe
2C. Non-Small Cell Lung Cancer Treated Patients in Europe
3. Non-Small Cell Lung Cancer Patient Flow in Germany
3A. Non-Small Cell Lung Cancer Prevalence in Germany
3B. Non-Small Cell Lung Cancer Diagnosed Patients in Germany
3C. Non-Small Cell Lung Cancer Treated Patients in Germany
4. Non-Small Cell Lung Cancer Patient Flow in France
4A. Non-Small Cell Lung Cancer Prevalence in France
4B. Non-Small Cell Lung Cancer Diagnosed Patients in France
4C. Non-Small Cell Lung Cancer Treated Patients in France
5. Non-Small Cell Lung Cancer Patient Flow in Spain
5A. Non-Small Cell Lung Cancer Prevalence in Spain
5B. Non-Small Cell Lung Cancer Diagnosed Patients in Spain
5C. Non-Small Cell Lung Cancer Treated Patients in Spain
6. Non-Small Cell Lung Cancer Patient Flow in Italy
6A. Non-Small Cell Lung Cancer Prevalence in Italy
6B. Non-Small Cell Lung Cancer Diagnosed Patients in Italy
6C. Non-Small Cell Lung Cancer Treated Patients in Italy
7. Non-Small Cell Lung Cancer Patient Flow in UK
7A. Non-Small Cell Lung Cancer Prevalence in UK
7B. Non-Small Cell Lung Cancer Diagnosed Patients in UK
7C. Non-Small Cell Lung Cancer Treated Patients in UK
8. Research Methodology
List of Tables
Table 1: Non-Small Cell Lung Cancer Patient Flow in Europe, 2016
Table 2: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 3: Non-Small Cell Lung Cancer Patient Flow in Germany, 2016
Table 4: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 5: Non-Small Cell Lung Cancer Patient Flow in France, 2016
Table 6: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2016 - 2025
Table 7: Non-Small Cell Lung Cancer Patient Flow in Spain, 2016
Table 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 9: Non-Small Cell Lung Cancer Patient Flow in Italy, 2016
Table 10: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 11: Non-Small Cell Lung Cancer Patient Flow in UK, 2016
Table 12: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2016 - 2025
List of Figures
Figure 1: Non-Small Cell Lung Cancer Patient Flow in Europe, 2016
Figure 2: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 3: Non-Small Cell Lung Cancer Patient Flow in Germany, 2016
Figure 4: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 5: Non-Small Cell Lung Cancer Patient Flow in France, 2016
Figure 6: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 7: Non-Small Cell Lung Cancer Patient Flow in Spain, 2016
Figure 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 9: Non-Small Cell Lung Cancer Patient Flow in Italy, 2016
Figure 10: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 11: Non-Small Cell Lung Cancer Patient Flow in UK, 2016
Figure 12: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report